FDA Adverse Event Injury Summary report: N

UNKNOWN

MDR report key: 3072062 · Received April 22, 2013

Report

Report Number
1030489-2013-01194
Event Type
Injury
Date Received
April 22, 2013
Report Date
July 6, 2015
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
UNKNOWN
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

BRAND NAME: UNKNOWN HARDWARE, INFUSE BONE GRAFT. (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT "MEDICALLY UNNECESSARY, EXPERIMENTAL" SPINE SURGERIES WHERE CERVICAL AND THORACIC RODS, SCREWS, CAGES AND RHBMP-2/ACS WERE IMPLANTED. THE PATIENT HAS SUSTAINED INJURY WITHIN THE PAST FOUR YEARS. THE PATIENT HAS ALLEGEDLY UNDERGONE RELATED FOLLOW UP CARE, PHYSICAL THERAPY, PRESCRIPTIONS, INJECTIONS, AND IMAGE STUDIES.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT UNDERWENT A SURGERY FOR INSTALLATION OF TWO RODS, SCREWS, AND REPLACEMENT OF SEVEN DISCS AT THE BACK WHICH INCLUDED THOROSCOPIC SURGERY T8-9, T9-10, T10-11, T11-12, T12- L1, L1-2 POSTERIOR SPINAL FUSION T 4- L 3. PATIENT SUFFERED FROM POST-OP BACK PAIN. PATIENT UNDERWENT REVISION SURGERY ON (B)(6) 2012. FOLLOWING THIS SURGERY THE PATIENT EXPERIENCED CONSTANT PAIN AND HAD DIFFICULTY WITH MOBILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
172564 UNKNOWN FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention